Logo

The role of imaging in evaluating patients with idiopathic inflammatory myopathies

1, 2, 3, 4, 5

  1. Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  2. MRC Centre for Neuromuscular Diseases, University College London, UK.
  3. Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  4. MRC Centre for Neuromuscular Diseases, University College London; Rheumatology Department, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.
  5. Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. vencovsky@revma.cz

CER11657 Submission on line
2018 Vol.36, N°5 ,Suppl.114 - PI 0074, PF 0081
Specific diseases

Free to view (click on article PDF icon to read the article)

Rheumatology Article

 

Abstract

OBJECTIVES:
To describe imaging modalities for diagnosing and monitoring of patients with idiopathic inflammatory myopathies.
METHODS:
A detailed literature search summarising recent data documenting the contribution of different imaging techniques to current management of idiopathic inflammatory myopathies was performed.
RESULTS:
An overview of methods most frequently used for evaluation of inflammatory myopathies and the description of their role in the diagnostic and monitoring process is presented.
CONCLUSIONS:
MRI is currently the most useful method capable of demonstrating both inflammatory and post-inflammatory changes in the muscles and surrounding soft tissue. Several studies have documented potential usefulness of other imaging techniques, such as ultrasonography, positron emission tomography, scintigraphy, and dual-energy x-ray absorptiometry.

PMID: 30296982 [PubMed]

Received: 23/08/2018 - Accepted : 30/08/2018 - In Press: 01/10/2018 - Published: 01/10/2018